Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Floxacillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.84 |
| ▸ | HPGD | P15428 | 4/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.76 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.75 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Floxacillin SCHEMBL14126462 | 1.00 | ABCB11 (1.00) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL22651560 | 1.00 | ABCB11 (1.00) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL1458003 | 1.00 | ABCB11 (1.00) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL1442294 | 0.99 | ABCB11 (0.98) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Dicloxacillin SCHEMBL21643600 | 0.99 | ABCB11 (0.98) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL855083 | 0.99 | ABCB11 (0.98) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL2636814 | 0.98 | ABCB11 (0.97) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Floxacillin SCHEMBL28086634 | 0.96 | ABCB11 (0.92) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Dicloxacillin SCHEMBL11407708 | 0.95 | ABCB11 (1.00) | ABCB11CYP1A2LMNAHPGDMEN1 | |
| Dicloxacillin SCHEMBL11407710 | 0.95 | ABCB11 (1.00) | ABCB11CYP1A2LMNAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 20174 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4431123-B1 | JELLYFISH COLLAGEN USE | JELLAGEN LTD (GB) | 2026-04-08 | — | — | EP | claimed |
| US-20260092102-A1 | COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN | REGENERON PHARMACEUTICALS, INC. | 2026-04-02 | — | — | US | claimed |
| EP-3475441-B1 | METHODS, SYSTEMS AND/OR KITS FOR DETECTING ANTIMICROBIAL RESISTANCE IN BACTERIA | BECTON DICKINSON CO (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4712972-A1 | COMBINATION THERAPY FOR BACTERIAL INFECTIONS COMPRISING ZINC-CHELATOR, BETA-LACTAM ANTIBIOTIC AND SERINE BETA-LACTAMASE INHIBITOR | Adjutec Pharma AS (NO) | 2026-03-25 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| WO-2026041873-A1 | COMPOSITIONS FOR SYSTEMIC ADMINISTRATION | THE UNIVERSITY OF READING (GB) | 2026-02-26 | — | — | WO | claimed |
| US-4594246-A | Antibiotics | LEO PHARMACEUTICAL PRODUCTS (DK) | 1986-06-10 | — | — | US | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
| EP-0029668-B1 | PHARMACEUTICAL INJECTABLE COMPOSITION AND TWO-PACK CONTAINER FOR SAID COMPOSITION | BEECHAM GROUP PLC (GB) | 1984-01-25 | — | — | EP | claimed |
| EP-0058015-A2 | Treatment of infections | BEECHAM GROUP PLC (GB) | 1982-08-18 | — | — | EP | claimed |
| EP-0010904-B1 | INTRAMAMMARY COMPOSITIONS AND PROCESS FOR THEIR PREPARATION | BEECHAM GROUP PLC (GB) | 1982-05-05 | — | — | EP | claimed |
| US-4324783-A | SYNERGISTIC COMBINATION OF PENCILLINS | TOYAMA CHEMICAL CO., LTD. (JP) | 1982-04-13 | — | — | US | claimed |
| EP-0029668-A1 | Pharmaceutical injectable composition and two-pack container for said composition | BEECHAM GROUP PLC (GB) | 1981-06-03 | — | — | EP | claimed |
| US-4217274-A | Methoxyethoxymethyl esters of penicillins | BRISTOL-MYERS COMPANY (US) | 1980-08-12 | — | — | US | claimed |
| US-4199566-A | DERIVATIVES OF PENICILLANIC ACID | TOYAMA CHEMICAL COMPANY, LIMITED (JP) | 1980-04-22 | — | — | US | claimed |
| US-4145429-A | VEGETALBE OIL, CLAY, ANTIBIOTIC | BEECHAM GROUP LIMITED (GB) | 1979-03-20 | — | — | US | claimed |